Astrana Health Inc (NASDAQ:ASTH) — Market Cap & Net Worth
Market Cap & Net Worth: Astrana Health Inc (ASTH)
Astrana Health Inc (NASDAQ:ASTH) has a market capitalization of $1.87 Billion ($1.87 Billion) as of September 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #6416 globally and #2028 in its home market, demonstrating a -1.05% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Astrana Health Inc's stock price $37.70 by its total outstanding shares 49604366 (49.60 Million). Also see how large is Astrana Health Inc's balance sheet for a full breakdown of the balance sheet.
Astrana Health Inc Market Cap History: 2015 to 2026
Astrana Health Inc's market capitalization history from 2015 to 2026. Data shows growth from $235.62 Million to $1.87 Billion (18.34% CAGR). Also see Astrana Health Inc (ASTH) cash conversion ratio for how efficiently the company converts equity into cash flow.
Index Memberships
Astrana Health Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.07% | #183 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #726 of 3165 |
Weight: Astrana Health Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Astrana Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Astrana Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for Astrana Health Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.39x
Astrana Health Inc's market cap is 0.39 times its annual revenue
Latest Price to Earnings (P/E) Ratio
54.73x
Astrana Health Inc's market cap is 54.73 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $372.03 Million | $57.43 Million | -$8.97 Million | 6.48x | N/A |
| 2017 | $1.19 Billion | $357.75 Million | $25.80 Million | 3.33x | 46.14x |
| 2018 | $984.65 Million | $519.91 Million | $10.84 Million | 1.89x | 90.88x |
| 2019 | $913.22 Million | $560.62 Million | $14.12 Million | 1.63x | 64.69x |
| 2020 | $906.27 Million | $370.25 Million | -$23.75 Million | 2.45x | N/A |
| 2021 | $3.64 Billion | $773.91 Million | $68.92 Million | 4.71x | 52.88x |
| 2022 | $1.47 Billion | $1.14 Billion | $45.17 Million | 1.28x | 32.49x |
| 2023 | $1.90 Billion | $1.39 Billion | $60.72 Million | 1.37x | 31.29x |
| 2024 | $1.56 Billion | $2.03 Billion | $43.15 Million | 0.77x | 36.25x |
| 2025 | $1.23 Billion | $3.18 Billion | $22.49 Million | 0.39x | 54.73x |
Competitor Companies of ASTH by Market Capitalization
Companies near Astrana Health Inc in the global market cap rankings as of September 17, 2026. Review Astrana Health Inc tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Astrana Health Inc by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #288 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #916 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1002 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1236 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #288 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $430.43 |
| #916 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €46.14 |
| #1002 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1236 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $265.78 |
Astrana Health Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Astrana Health Inc's market cap moved from $235.62 Million to $ 1.87 Billion, with a yearly change of 18.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.87 Billion | +51.95% |
| 2025 | $1.23 Billion | -21.31% |
| 2024 | $1.56 Billion | -17.68% |
| 2023 | $1.90 Billion | +29.44% |
| 2022 | $1.47 Billion | -59.73% |
| 2021 | $3.64 Billion | +302.19% |
| 2020 | $906.27 Million | -0.76% |
| 2019 | $913.22 Million | -7.25% |
| 2018 | $984.65 Million | -17.29% |
| 2017 | $1.19 Billion | +220.00% |
| 2016 | $372.03 Million | +57.89% |
| 2015 | $235.62 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Astrana Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.87 Billion USD |
| MoneyControl | $1.87 Billion USD |
| MarketWatch | $1.87 Billion USD |
| marketcap.company | $1.87 Billion USD |
| Reuters | $1.87 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Astrana Health Inc
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health … Read more